Mouse in Vivo Neutralization of Escherichia coli Shiga Toxin 2 with Monoclonal Antibodies

Disease-Enhancing Antibodies Improve the Efficacy of Bacterial Toxin-Neutralizing Antibodies

(2013) Siu-Kei Chow et al.   Cell Host & Microbe

Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice

(2012) Abhineet Sheoran et al.   BMC IMMUNOLOGY

Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak

(2012) Diana Corogeanu et al.   BMC MICROBIOLOGY

Risk Factors for the Hemolytic Uremic Syndrome in Children Infected With Escherichia coli O157:H7: A Multivariable Analysis

(2012) C. S. Wong et al.   CLINICAL INFECTIOUS DISEASES

Need for Long-term Follow-up in Enterohemorrhagic Escherichia coli–Associated Hemolytic Uremic Syndrome Due to Late-Emerging Sequelae

(2012) Alejandra Rosales et al.   CLINICAL INFECTIOUS DISEASES

Multicenter Evaluation of a Sequence-Based Protocol for Subtyping Shiga Toxins and Standardizing Stx Nomenclature

(2012) F. Scheutz et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Development and characterization of monoclonal antibodies against Shiga toxin 2 and their application for toxin detection in milk

(2012) Xiaohua He et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Renal and neurological involvement in typical Shiga toxin-associated HUS

(2012) Howard Trachtman et al.   Nature Reviews Nephrology

Shiga toxin type 2 (Stx2), a potential agent of bioterrorism, has a short distribution and a long elimination half-life, and induces kidney and thymus lesions in rats

(2011) Yue-Nan Liu et al.   ARCHIVES OF TOXICOLOGY

Shiga Toxin Subtypes Display Dramatic Differences in Potency

(2011) Cynthia A. Fuller et al.   INFECTION AND IMMUNITY

Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: Isolation, purification and neutralization efficacy

(2011) Y.R. Parma et al.   TOXICON

In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2

(2010) Kwang-il Jeong et al.   BMC IMMUNOLOGY

Shiga Toxin 2–Specific but Not Shiga Toxin 1–Specific Human Monoclonal Antibody Protects Piglets Challenged with EnterohemorrhagicEscherichia coliProducing Shiga Toxin 1 and Shiga Toxin 2

(2010) Kwang‐il Jeong et al.   JOURNAL OF INFECTIOUS DISEASES

Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7

(2010) Krystle L. Mohawk et al.   VACCINE

Efficient Serum Clearance of Botulinum Neurotoxin Achieved Using a Pool of Small Antitoxin Binding Agents

(2009) J. Sepulveda et al.   INFECTION AND IMMUNITY

Antibody Protection against Botulinum Neurotoxin Intoxication in Mice

(2009) L. W. Cheng et al.   INFECTION AND IMMUNITY

Treatment options for HUS secondary to Escherichia coli O157:H7

(2009) Martin Bitzan   KIDNEY INTERNATIONAL

Mouse Model of Hemolytic-Uremic Syndrome Caused by Endotoxin-Free Shiga Toxin 2 (Stx2) and Protection from Lethal Outcome by Anti-Stx2 Antibody

(2008) K. A. D. Sauter et al.   INFECTION AND IMMUNITY

Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome

(2008) Gema Ariceta et al.   PEDIATRIC NEPHROLOGY